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Abstract. Voltage-dependent calcium channels (VDCCs) 
are key elements in epileptogenesis. There are several 
binding-sites linked to calmodulin (CaM) and several poten-
tial CaM-dependent protein kinase II (CaMKII)-mediated 
phosphorylation sites in CaV1.2. The tremor rat model 
(TRM) exhibits absence-like seizures from 8 weeks of 
age. The present study was performed to detect changes in 
the Ca2+/CaV1.2/CaM/CaMKII pathway in TRMs and in 
cultured hippocampal neurons exposed to Mg2+-free solution. 
The expression levels of CaV1.2, CaM and phosphorylated 
CaMKII (p-CaMKII; Thr-286) in these two models were 
examined using immunofluorescence and western blotting. 
Compared with Wistar rats, the expression levels of CaV1.2 
and CaM were increased, and the expression of p-CaMKII 
was decreased in the TRM hippocampus. However, the 
expression of the targeted proteins was reversed in the TRM 
temporal cortex. A significant increase in the expression of 
CaM and decrease in the expression of CaV1.2 were observed 
in the TRM cerebellum. In the cultured neuron model, 
p-CaMKII and CaV1.2 were markedly decreased. In addition, 
neurons exhibiting co-localized expression of CaV1.2 and 
CaM immunoreactivities were detected. Furthermore, intra-
cellular calcium concentrations were increased in these two 
models. For the first time, o the best of our knowledge, the 
data of the present study suggested that abnormal alterations 
in the Ca2+/CaV1.2/CaM/CaMKII pathway may be involved in 
epileptogenesis and in the phenotypes of TRMs and cultured 
hippocampal neurons exposed to Mg2+-free solution.
Introduction
Epilepsy is one of the most common neurological conditions and 
is a set of chronic brain diseases caused by abnormal discharge 
of neurons within a brief time-frame (1). Voltage-dependent 
calcium channels (VDCCs) have important effects on 
neurotransmitter release and membrane excitability (2,3). 
CaV1.2 is the most predominant VDCC located in certain 
dendrites of hippocampal and cortical neurons (4-6). Previous 
studies have demonstrated that abnormal expression of CaV1.2 
is present in different epilepsy phenotypes (7-9). At early stages 
during and following pilocarpine-induced status epilepticus, 
significant changes of CaV1.2 have been found in different 
groups of hippocampal neurons (7). However, no changes 
were observed in the protein expression of CaV1.2 in inferior 
colliculus neurons of genetically epilepsy-prone rats, compared 
with control Sprague-Dawley rats (3). There are at least four 
binding-sites linked to calmodulin (CaM) and several potential 
CaM-dependent protein kinase II (CaMKII)-mediated phos-
phorylation sites in CaV1.2 (8-11). Binding of Ca2+ produces 
a conformational change in CaM, exposing hydrophobic resi-
dues that promote interactions of the Ca2+/CaM complex with 
CaV1.2 (12). The Ca2+/CaM complex can enhance the affinity 
of CaM and the activity of CaV1.2 (13-16). Thus, CaM is 
important as a Ca2+ sensor for Ca2+-dependent facilitation and 
inactivation (17,18). CaMKII is a multifunctional serine/threo-
nine kinase, which can mediate several Ca2+-dependent neuronal 
processes, and it accounts for 0.5-1.0% of total brain protein and 
up to 2% of hippocampal protein (19,20). CaMKII is activated 
by auto-phosphorylation when it is combined with the Ca2+/CaM 
complex. Additionally, phosphorylated-CaMKII (p-CaMKII) 
exhibits its biological activity by the phosphorylation of other 
target proteins (21,22). With the involvement of CaMKII, the 
activity of CaV1.2 is promoted by CaM (23,24). A previous 
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study demonstrated immediate inhibition of cortical and 
hippocampal CaM kinase II activity in homogenate following 
the development of status epilepticus in a rat pilocarpine 
model (25). However, the roles of CaV1.2, CaM and CaMKII, 
and their interactions in epilepsy are controversial and remain 
to be fully elucidated. The tremor rat model (TRM; tm/tm) is 
an animal model of epilepsy, which is a genetic mutant first 
discovered in a Kyoto-Wistar colony (26). TRM is regarded 
as a useful model of epilepsy due to its similarity in pathogen-
esis and treatment to the human condition (27). Hippocampal 
neurons exposed to Mg2+-free solution are well suited to 
biochemical and electrophysiological investigations to elucidate 
the cellular mechanisms, which lead to epileptogenesis (28), as 
the spontaneous epileptiform discharges produced by hippo-
campal neurons exposed to Mg2+-free solution is similar to the 
electrical activity of epileptic seizures in humans. Thus, the 
aim of the present study was to investigate the alterations of the 
selected Ca2+/CaV1.2/CaM/CaMKII pathway in the TRM and 
in cultured hippocampal neurons exposed to Mg2+-free solution, 
in vivo and in vitro, respectively. These investigations aimed 
to obtain an insight into the pathways in producing neuronal 
excitability.
Materials and methods
Animals. The TRM is an animal model of epilepsy and the tm 
genetic mutant was identified in a Kyoto‑Wistar colony (29). 
In the present study, 15 normal Wistar rats and 15 TRMs 
aged between 9 and 12 weeks were housed in individual 
cages under a controlled environment (12:12 h light/dark 
cycle, 50‑70% humidity, 24˚C) with free access to food and 
water. The present study was performed in strict accordance 
with the recommendations in the Guide for the Care and 
Use of Laboratory Animals of the National Institutes of 
Health (15,16). The animal use protocol was reviewed and 
approved by the Institutional Animal Care and Use Committee 
of China Medical University (Shenyang, China).
Electroencephalographic (EEG) determination and evaluation. 
The experimental animals (five animals per group) were anes-
thetized with 10% chloral hydrate (intraperitonal, 0.3 ml/100 g) 
and the animals were implanted with EEG electrodes (BL-420F; 
Taimeng Co., Ltd., Chengdu, China). Cortical and hippocampal 
electrodes were chronically implanted onto the cortex (3.0 mM 
lateral and 3.0 mM rostral to the bregma on the cranium) and in 
the left hippocampus (2.0 mM lateral and 4.0 mM caudal to the 
bregma and 3.0 mM from the cortical surface), respectively (30). 
Over the 7 days following this procedure, the EEG was recorded 
using a pen-writing polygraph. Following habituation of the rats 
in a soundproof box (40x40x40 cm) for >20 min, the EEG was 
recorded for 30 min. The rat was exposed to puff stimulation 
on the face by a researcher every 5 min to ensure the animal 
remained aroused during the recording period. Changes in the 
EEG during absence-like seizures consistently correlated with 
the abnormal seizure behavior, as described previously (29). 
When 5-7 Hz spike-wave-like complexes in the cortical and 
hippocampal EEG lasted for >1 sec, the response was consid-
ered as one absence-like seizure. When the time interval 
between two independent 5-7 Hz spike-wave-like complexes 
was <1 sec, the two events were considered as a single seizure.
Primary neuronal cell cultures. Hippocampal neuronal 
cells, which were obtained from rats born within 1 day of 
each other, were dissociated in Hanks' balanced salt solu-
tion containing 0.125% trypsin (Sigma-Aldrich, St. Louis, 
MO, USA) for 10 min at 37˚C. The cells were then plated 
onto dishes at 2x105 cells/cm2 in Dulbecco's modified 
Eagle's medium (Gibco-BRL, Invitrogen Life Technologies, 
Carlsbad, CA, USA) containing 15% fetal bovine serum and 
penicillin-streptomycin, (100 U/ml, Gibco-BRL). Following 
plating for 24 h, the medium was replaced with Neurobasal™ 
medium supplemented with 2% B27 (Gibco-BRL). The hippo-
campal neuronal cell media was refreshed every 3-4 days. 
Hippocampal neurons at the 12th day of in vitro culture were 
used in the following experiments.
Establishment of the hippocampal neuronal culture model. The 
in vitro hippocampal neuronal culture model was established 
according to Sombati's method (31). For primary neuronal cell 
cultures, maintenance medium was replaced with physiological 
recording solution for 3 h (Beyotime Institute of Biotechnology, 
Haimen, China) with or without MgCl2 (1 mM). The solution 
contained 145 mM NaCl, 2.5 mM KCl, 10 mM HEPES, 2 mM 
CaCl2, 10 mM glucose and 0.002 mM glycine (pH 7.3), the 
osmolarity of which was adjusted to 290±10 mOsm using 
sucrose. Continuous epileptiform high-frequency bursts were 
induced by exposing the neuronal cultures to physiological 
recording solution without MgCl2 (Mg2+-free) for 3 h, following 
which the culture was exposed to physiological recording solu-
tion. For double‑labeling immunofluorescence and western 
blotting, the cultures were exposed to physiological solution 
for 8 h following treatment with Mg2+-free solution for 3 h 
prior to use of the hippocampal neurons in these experiments. 
For measurement of intracellular calcium concentration, the 
cultures were exposed to Mg2+-free solution of 3 h, following 
which the hippocampal neurons were used immediately.
Electrophysiological recordings. The electrophysiological 
recording method used in the present study was that used 
in our previous study (32). The extracellular bath contained 
135 mM NaCl, 5.4 mM KCl, 1.0 mM MgCl2, 0.33 mM 
NaH2PO4, 10 mM HEPES and 5.5 mM glucose (pH 7.4; 
NaOH). The pipette solution contained 50 mM K-Aspartate, 
20 mM KCl, 20 mM HEPES, 1 mM EGTA, 1 mM MgCl2, 
0.2 mM CaCl2, 13.6 mM NaCl and 3 mM K2ATP3 (pH 7.4; 
KOH; Beyotime Institute of Biotechnology). Patch-clamp 
electrodes were obtained with capillary tubes pulled with a 
P-97 puller (Gibco-BRL). The electrodes had a resistance of 
~2.5-4 MΩ. Patch clamp was performed using an AxoPatch 
200B amplifier (Axon Instruments, Foster City, CA, USA). To 
record action potential, cultures, including the normal cultured 
neurons and the neurons treated with Mg2+-free solution, were 
transferred to the stage of an inverted microscope (TMS-1015, 
Olympus, Tokyo, Japan). Patch-clamp was performed utilizing 
the whole-cell current-clamp gap-free recording mode.
Western blot analysis. Proteins from the tissues and neurons 
were extracted by lysis in radioimmunoprecipitation assay 
buffer (Beyotime Institute of Biotechnology) with ultra-
sonication, followed by centrifugation and retrieval of the 
supernatant. The concentrations of extracted proteins from the 
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tissues and neurons were determined using a bicinchoninic 
acid protein assay kit (Beyotime Institute of Biotechnology). 
The protein samples (50 µg per lane) were separated by 
10% SDS-PAGE (Beyotime Institute of Biotechnology) 
and transferred onto polyvinylidene difluoride membranes 
(Motimo Membrane Technology Co., Ltd., Tianjin, China). 
The membranes were blocked for 1 h at room temperature 
with 5% bovine serum albumin (BSA) in tris-buffered saline 
with Tween 20 (TTBS; Beyotime Institute of Biotechnology) 
containing 50 mM Tris-HCl; 0.1% Tween-20 and 154 mM NaCl 
(pH 7.4), followed by 2 h incubation. The membranes were then 
incubated overnight at 4˚C in TTBS containing the following 
primary antibodies: Rabbit anti-CaV1.2 (1:500; cat no. ab-81095; 
Abcam, Cambridge, MA, USA), rabbit anti-CaMKII (1:500; 
cat no. sc-9035; Santa Cruz Biotechnology, Inc., Dallas, TX, 
USA), rabbit anti-p-CaMKII (1:500; cat no. sc-3228; Santa 
Cruz Biotechnology, Inc.; the epitope corresponding to a short 
amino acid sequence containing phosphorylated Thr-286 of 
CaMKII α), mouse anti-CaM (1:800; cat no. sc-137079; Santa 
Cruz Biotechnology, Inc.) and β-actin (1:1,000; cat no. sc-47778; 
Santa Cruz Biotechnology, Inc.). Following several washes in 
TTBS, the membranes were incubated for 1 h at room tempera-
ture in horseradish peroxidase-conjugated goat anti-mouse 
IgG or horseradish peroxidase-conjugated goat anti-rabbit 
IgG (1:5,000; cat nos. sc-2005 and sc-2054, respectively; 
Santa Cruz Biotechnology, Inc.) for 2 h at room temperature. 
Immunoreactive bands were visualized using an enhanced 
chemiluminescence kit. The levels of protein were evaluated by 
measuring the optical densities of the protein bands using Scion 
Image (4.03) for Windows image-analysis software. β-actin 
was used as a control to demonstrate that equal quantities of 
protein were loaded. Similarly, CaMKII was used as a control 
to demonstrate that equal quantities of p-CaMKII were loaded.
Double‑labeling immunofluorescence. The TRMs and 
control rats were anesthetized with 10% chloral hydrate (i.p., 
0.35 ml/100 g). Following intracardial perfusion with 4% para-
formaldehyde, the brains of the rats were rapidly removed 
and placed in 4% paraformaldehyde solution for 24 h at room 
temperature and 30% sucrose solution for 24 h at 4˚C. The 
dehydrated‑fixed brains were then frozen and 10-µm serial 
coronal sections were cut using a cryostat (CM1900 UV; Leica 
Microsystems GmbH, Wetzlar, Germany). These sections, and 
the Mg2+-free treated and normal hippocampal neurons, were 
rinsed in phosphate-buffered saline (PBS; 0.01 M; pH 7.4) 
for 15 min and incubated in PBS (0.01 M; pH 7.4), which was 
supplemented with 0.25% Triton X-100 (Sigma-Aldrich) and 
10% BSA (Gibco-BRL) for 1 h for blocking and penetration. 
The sections and neurons were then incubated overnight at 
4˚C in a mixture of the following primary antibodies: Mouse 
anti-CaM (1:100; Santa Cruz Biotechnology, Inc.) and rabbit 
anti-CaV1.2 (1:80; Abcam) or mouse anti-CaM (1:100; Santa 
Cruz Biotechnology, Inc.) and rabbit anti p-CaMKII (1:100; 
Santa Cruz Biotechnology, Inc.). PBS without primary 
antibodies was used as a negative control. Following rinsing 
with 0.01 M PBS three times, for 5 min each, the sections 
and neurons were incubated with fluorescein isothiocyanate 
(FITC)- and Cy3-conjugated goat anti-mouse or anti-rabbit 
antibodies (1:200; ZSGB-BIO, Beijing, China) for 2 h at 
room temperature in the dark. Finally, sections from different 
brain regions, including the hippocampus (CA1, CA3 and 
DG), temporal cortex and cerebellum, were examined. The 
sections and neurons were examined using a Confocal laser 
scanning biological microscope (Fluoview FV500; Olympus 
Corporation, Tokyo, Japan). CaV1.2 and p-CaMKII were 
labeled with FITC-emitting green light, CaM was labeled 
with tetramethylrhodamine-emitting red light, with yellow 
light representing the co-localization of CaV1.2 and CaM or 
p-CaMKII and CaM. The co-localized cells that were clearly 
yellow were selected as positive cells, and the number of posi-
tive cells in every 100 cells was determined.
Acute dissociation of neurons. Acute dissociation of neurons 
was performed using a previous method with certain modifi-
cations (33). The experimental animals were anesthetized with 
10% chloral hydrate (intraperitoneal, 0.3 ml/100 g) and then 
quickly sacrificed by decapitation. The brains were rapidly 
removed and placed in Hank's balanced salt solution (Gibco Life 
Technologies). The tissues (hippocampus, temporal cortex and 
cerebellum) were separated and cut into 400 µm-thick slices. 
These slices were incubated in artificial cerebrospinal fluid 
(Beyotime Institute of Biotechnology) containing 126 mM 
NaCl, 5 mM KCL, 2 mM CaCl2, 25 mM NaHCO3, 1.5 mM 
NaH2PO4, 2 mM MgSO4 and 10 mM glucose (32˚C; 5% CO2; 
pH adjusted to 7.4 with NaOH) for at least 1 h. The tissue slices 
were dissociated using 0.125% trypsin (Sigma-Aldrich) for 
30 min at 37˚C, and the dissociated tissues were then rinsed 
three times in extracellular fluid containing 130 mM NaCl; 
5.4 mM KCl; 1 mM MgCl2; 1 mM CaCl2; 10 mM HEPES 
and 25 mM glucose (32˚C; 5% CO2; pH adjusted to 7.4 with 
NaOH), and triturated mechanically with a graded series of 
fire‑polished Pasteur pipettes of ~500, 300 and 150 µm (Leiqi 
Experiment Equipment Co., Ltd., Hangzhou, China, succes-
sively. Following standing for 2 min, the upper cells in the cell 
suspension were plated onto culture dishes (1x106 cells/ml) 
in extracellular fluid. The acute isolated neurons were used 
within 6 h. All experimental procedures were maintained in a 
humidified atmosphere under 5% CO2.
Measurement of intracellular calcium concentration ([Ca2+]i). 
The measurement of [Ca2+] I was performed, according to that 
described in our previous study (34). The acutely dissociated 
neurons and Mg2+-free treated hippocampal neurons were 
incubated for 20 min with 5 µm fluo‑3 acetoxymethylester 
(fluo‑3/AM; Molecular Probes Life Technologies, Carlsbad, 
CA, USA; 32˚C; 5% CO2; pH adjusted to 7.4 with NaOH). The 
neurons of the control group and model group were plated 
into two cell culture cover glasses in the same dish. Thus, the 
control and model neurons were treated using the same proce-
dure. The labeled neurons were then rinsed three times with 
PBS and cultured for 30 min to exclude non‑specific staining 
of the extracellular fluid (32˚C; 5% CO2). The preparations 
were observed and quantitatively analyzed using a confocal 
laser scanning biological microscope (Fluoview FV500; 
Olympus, Corporation). The visual field was selected where 
at least five neurons contained fluo‑3/AM, which was excited 
by the 488 nm line of a 200 mW argon ion laser and captured 
at wavelengths >505 nm. The data were expressed as relative 
fluorescence intensities. Confocal imaging was performed on 
three separate fields of cells for each group. The concentration 
LV et al:  CA2+/CaV1.2/CAM/CaMKII IN EPILEPSY4
of intracellular Ca2+ was expressed as the relative fluorescent 
intensity using ImageJ 1.46 software (National Institutes of 
Health, Bethesda, MD, USA).
Statistical analysis. Values are expressed as the mean ± stan-
dard deviation, and statistical analysis were performed using 
SPSS 13.0 statistical software (SPSS, Inc., Chicago, IL, USA). 
Statistical significance was determined using Student's t-test 
and one-way analysis of variance was used for comparisons. 
P<0.05 was considered to indicate a statistically significant 
difference.
Results
Spontaneous discharge activity in the EEG recording in the 
TRM and Mg2+‑free treatment model. The EEG recording 
of The control rats and TRMs were detected in the hippo-
campus and cerebral cortex, respectively. It did not reveal 
any abnormal discharges in The control rat hippocampus 
or cerebral cortex (Fig. 1Aa), however, a 6 Hz spike and 
wave complex was recorded during absence-like seizure in 
the TRM hippocampus and cerebral cortex (Fig. 1Ab). In 
addition, the whole-cell current-clamp technique was used 
to record the electrical physiological activities of normal 
neurons (n=6) and Mg2+-free treated neurons (n=6). The 
results demonstrated that representative neurons during 3 h 
exposure to physiological recording solution containing 
1 mM MgCl2 produced a normal baseline activity, presenting 
with occasional action potentials (Fig. 1Ba). However, expo-
sure of the Mg2+-free treated neurons, which were exposed 
for 3 h to Mg2+-free recording solution, produced continuous 
high frequency epileptiform discharges (Fig. 1Bb). These 
data indicated that the in vivo and in vitro modelS of epileptic 
discharge in the present study had been established success-
fully.
Abnormal protein expression of CaV1.2, CaM, p‑CaMKII 
and CaMKII in the TRM and Mg2+‑free treatment model. 
Western blot analysis was performed to quantify and 
compare selected the protein expression levels in the TRMs 
(n=6) and control rats (n=6). The western blot was probed 
with antibodies to CaV1.2, CaM, p-CaMKII and CaMKII, 
Figure 2. Protein expression levels of CaV1.2, CaM, p-CaMKII and CaMKII 
in the TRM and hippocampal cultured neurons exposed to Mg2+-free by 
western blotting. (A) Immunoblots and quantitative analysis of the protein 
levels of CaV1.2, CaM, p-CaMKII and CaMKII in the TRM hippocampal 
and control groups (n=6). (B) Immunoblots and quantitative analysis of the 
protein levels of CaV1.2, CaM, p-CaMKII and CaMKII in the TRM cortex 
and control groups (n=6). (C) Immunoblots and quantitative analysis of the 
protein levels of CaV1.2, CaM, p-CaMKII and CaMKII in the TRM cer-
ebellum and control groups (n=6). (D) Immunoblots and quantitative analysis 
of the protein levels of CaV1.2, CaM, p-CaMKII and CaMKII in the in vitro 
model (n=6) and control groups (n=6). **P<0.01, vs. control group; *P<0.05, 
vs. control group (analysis of variance followed by Student's t-test). Data are 
presented as the mean ± standard deviation. TRM, tremor rat model; CaM, 
calmodulin; CMKII, CaM-dependent protein kinase II; p-, phosphorylated.
Figure 1. Electroencephalogram  recording of the TRM and induction of ‘epileptiform discharge’ in the cultured hippocampal neurons by Mg2+-free treatment. 
(A) In the TRM, (a) normal discharge was detected in the control rat hippocampus and cerebral cortex. (b) a 6 Hz spike and wave complex was detected during 
absence-like seizure in the TRM hippocampus and cerebral cortex. (B) In the neuron model, (a) occasional spontaneous action potentials were detected in the 
normal neuron; (b) spontaneous recurrent ‘epileptiform discharge’ was detected in a Mg2+-free treated neuron. TRM, tremor rat model.
  A
  B
  A
  B
  C
  D
  a
  a
  b
  b
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and their respective anticipated bands at 240 kDa, 17 kDa 
and 50 kDa were detected, respectively. In the TRMs, 
hippocampal quantification analysis revealed that the levels of 
expression of CaV1.2 (P=0.0017) and CaM (P=0.0001) were 
increased significantly, while those of p‑CaMKII (P=0.0001) 
were decreased significantly, compared with the control 
rats. No change was observed in the expression of CaMKII 
(P=0.08), compared with control groups (Fig. 2A). Notably, 
the situation was reversed in the protein expression patterns of 
the TRM temporal cortex. The expression levels of of CaV1.2 
(P=0.0001) and CaM (P=0.0130) were significantly lower than 
those in the control group. Compared with the control rats, 
the expression of p‑CaMKII (P=0.0017) was increased signifi-
cantly. No change was detected in the expression of CaMKII 
(P=0.77), compared with the control group (Fig. 2B). In addi-
tion, these findings verified upregulation of the expression 
of CaM (P=0.0001) and downregulation in the expression of 
CaV1.2 (P=0.0019) at the protein level in the TRM cerebellum. 
No changes occurred in the protein expression of p-CaMKII 
(P=0.3700) or CaMKII (P=0.72), compared with the control 
group (Fig. 2C). In the hippocampal Mg2+-free neuron 
epileptiform discharge model, no significant differences were 
observed in the expression of CaM (P=0.9799), compared 
with the control neurons, while p-CaMKII (P=0.0006) and 
CaV1.2 (P=0.0001) were decreased, compared with the control 
neurons. No change was observed in the protein expression of 
CaMKII (P=0.43), compared with the control group (Fig. 2D).
Co‑localization of CaV1.2 with CaM, and p‑CaMKII 
with CaM in the TRM and Mg2+‑free treatment model. 
Immunofluorescence analyses were performed in the two 
model (n=5) and control group (n=5) using anti-CaV1.2, 
anti-CaM and anti-p-CaMKII to detect the distributions 
and expression levels. As shown in Fig. 3A, in the TRM 
Figure 3. Co-localization of CaV1.2 and CaM in the TRM and in vitro model, detected using immunofluorescence. CaV1.2 was labeled with fluorescein 
isothiocyanate-emitting green light, CaM was labeled with tetramethylrhodamine-emitting red light, with yellow light indicating the co-localization of CaV1.2 
and CaM. (A) TRM hippocampus CA1, CA3 and DG region. (B) Number of positive cells for CaV1.2-CaM in the TRM hippocampus. **P<0.01, vs. control 
group; *P<0.05, vs. control group (ANOVA followed by Student's t-test; n=5). (C) TRM cortex, cerebellum and Mg2+-free hippocampal neurons. (D) Number 
of positive cells for CaV1.2-CaM in the TRM cortex, cerebellum and in Mg2+-free hippocampal neurons. **P<0.01, vs. control group; *P<0.05, vs. control group 
(ANOVA followed by Student's t-test, n=5). Scale bar=50 µm. Data are presented as the mean ± standard deviation. TRM, tremor rat model; CaM, calmodulin; 
CMKII, CaM-dependent protein kinase II; ANOVA, analysis of variance.
  A
  B
  C
  D
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hippocampus, compared to control group, the CaV1.2 and 
CaM immunopositive neurons were stained markedly in CA1 
and CA3 areas, while in DG areas, they were not expressed 
as highly as they were in the CA1 or CA3 areas. CaV1.2 
was concentrated in the soma and proximal dendrites of the 
pyramidal neurons (green), and CaM was primarily localized 
to the cytoplasm (red). It was of interest to note that CaV1.2 
co-localized with CaM. Overlapping localization of these 
proteins (yellow) were evident in the CA1 (P=0.0044), CA3 
(P=0.0050) and DG (P=0.0060) areas when the images of 
their individual staining patterns were merged (Fig. 3B). As 
indicated in Fig. 3C and D, in the TRM cortex, the number 
of co-localization cells for CaV1.2-CaM was decreased, 
compared with that of the normal rats (P=0.0417). In the cere-
bellum, the number of co-localization cells for CaV1.2-CaM 
was not changed, compared with the controls (P=0.4771). In 
the Mg2+-free treated neuron model, CaV1.2 was localized 
to the cell membrane, while CaM was localized to the cell 
membrane and the cytoplasm. The number of co-localization 
cells for CaV1.2-CaM in the Mg2+-free treated model was 
decreased compared with normal neurons (P=0.0075). 
In addition, p-CaMKII immunopositive neurons (green) 
were localized in the cytoplasm of cells in hippocampus. 
Compared with the controls, the numbers of co-localization 
cells of CaM-p-CaMKII in the CA1 (P=0.0480) and CA3 
(P=0.0289) of the TRM hippocampus were increased, respec-
tively, however, there was no change in the DG (P=0.5675, 
Fig. 4A and B). It was clear that the distribution pattern of 
p-CaMKII was widely localized in the cytoplasm of cortical 
cells, which was similar to that observed in the hippocampus 
(Fig. 4C). There was no significant change of overlapping 
localization of p-CaMKII and CaM in the temporal cortex 
(P=0.9631; Fig. 4C and D). In the cerebellum of the TRM, 
the number of CaM-p-CaMKII-positive cells was also 
Figure 4. Co-localization of p-CaMKII and CaM in the TRM and in vitro model, detected using immunofluorescence. The p‑CaMKII was labeled with fluores-
cein isothiocyanate-emitting green light and CaM was labeled with tetramethylrhodamine-emitting red light, with  yellow light indicating the co-localization 
of p-CaMKII and CaM. (A) TRM hippocampus CA1, CA3 and DG regions. (B) Number of positive cells for p-CaMKII-CaM in the TRM hippocampus. 
**P<0.01, vs. control group; *P<0.05, vs. control group (ANOVA followed by Student's t-test; n=5). (C) TRM cortex, cerebellum and Mg2+-free hippocampal 
neurons. (D) Number of positive cells for p-CaMKII-CaM in the TRM cortex, cerebellum and in Mg2+-free hippocampal neurons. **P<0.01, vs. control group; 
*P<0.05, vs. control group (ANOVA followed by Student's t-test; n=5). Scale bar=50 µm. Data are presented as the mean ± standard deviation. TRM, tremor 
rat model; CaM, calmodulin; CMKII, CaM-dependent protein kinase II; p-, phosphorylated.
  A   B
  C   D
MOLECULAR MEDICINE REPORTS  7
unchanged (P=0.7792; Fig. 4C and D). However, in the in vitro 
model, there was a decrease in the number of p-CaMKII and 
CaM co-localization neurons, compared with the controls 
(P=0.0059; Fig. 4C and D).
Measurement of intracellular calcium concentration in the 
TRM and Mg2+‑free treatment model. Compared with the 
controls (n=5), the [Ca2+] I relative fluorescence intensity 
of the model groups (n=5), including the TRMs (hippo-
campus, cortex and cerebellum; Fig. 5A-C) and Mg2+-free 
hippocampal neurons (Fig. 5D) were increased, as shown in 
Fig. 5E and F.
Discussion
The predominant aims of the present study were to examine 
the changes in Ca2+/CaV1.2/CaM/CaMKII in the TRM and 
in the hippocampal Mg2+-free neuron epileptiform discharge 
models; and to demonstrate the possible correlation between 
CaV1.2 and the CaM/CaMKII pathway in these models. 
Epileptic models are fundamental to the investigation of the 
pathogenesis and possible treatments for epilepsy. TRMs 
were used in the present study as they are similar to the 
relevant human disease (27). TRM is an ideal model for the 
investigation of absence-like seizures, and seizures linked 
with the tm mutant, which was mapped to rat chromosome 
10 (35). Furthermore, the paroxysmal occurrence of a 5-7 Hz 
spike-wave complexes can be recorded in the hippocampal and 
cortical areas after 8 weeks (29). In addition, the hippocampal 
Mg2+-free neuron epileptiform discharge model is a common 
model of epileptiform discharge in vitro (36).
In the present study, Mg2+-free treated hippocampal neurons 
produced continuous high frequency epileptiform discharges, 
which corresponded to observations in our previous study 
using whole-cell current-clamp (32). In the present study, the 
[Ca2+] I fluorescence intensity was increased in the TRMs 
(hippocampus, temporal cortex and cerebellum) and in the 
in vitro model, indicating that Ca2+ mayt be a key element 
in the epileptogenesis of these two models. [Ca2+] I led to 
the depolarization of cells, activating the inflow of Na+ and 
further enhancing epilepsy (37,38). Previous studies demon-
strated that status epilepticus causes sustained elevation of 
intracellular calcium levels in the hippocampal neuronal 
culture model (39,40). In addition, calcium influx is enhanced 
in hippocampal CA3 neurons of spontaneously epileptic 
rats (41), which is in agreement with the results of the present 
study. A prominent finding in the present study was that the 
protein expression of CaV1.2 was increased significantly in 
the TRM hippocampus. However, the protein expression 
levels of CaV1.2 were decreased in the cortex, cerebellum and 
in in vitro culture. Previous studies have demonstrated that 
VDCC is essential in neuronal excitability (42). Transient and 
selective upregulation of CaV3.2 subunits on the mRNA and 
protein levels following status epilepticus causes an increase 
in cellular T-type Ca2+ currents and a transitional increase in 
intrinsic burst firing (43). Enhancements of Ca2+ influx into 
hippocampal CA3 neurons, due to the easier activation proper-
ties of VDCCs, are involved in SER epileptic seizures (44). 
In addition, VDCC currents are enhanced in the hippocampus 
Figure 5. [Ca2+]i relative fluorescence intensity in the TRM and the cul-
tured hippocampal neurons exposed to Mg2+-free. (A) [Ca2+]i relative 
fluorescence intensity in the TRM hippocampus. (B) [Ca2+]i relative fluores-
cence intensity in the TRM cortex. (C) [Ca2+]i relative fluorescence intensity 
in the TRM cerebellum. (D) [Ca2+]i relative fluorescence intensity in the 
Mg2+‑free hippocampal neurons. (E) Quantification of the relative fluores-
cence intensities in the TRM, compared with the control and (F) Mg2+-free 
hippocampal neurons, compared with the control. **P<0.01, vs. control 
(analysis of variance followed by Student's t-test; n=5). Scale bar=50 µm. 
Data are presented as the mean ± standard deviation. TRM, tremor rat model.
  A
  B
  C
  D
  E
  F
LV et al:  CA2+/CaV1.2/CAM/CaMKII IN EPILEPSY8
of patients with temporal lobe epilepsy (45). Another study 
reported that the expression of CaV1.2 was significantly 
reduced in Stargazer mouse cerebellar synapses, compared 
with their non-ataxic littermates, however, no differences were 
detected in hippocampal synapses (5). Accordingly, these find-
ings have indicated the importance of CaV1.2 in the epileptic 
brain. The increased expression of CaV1.2 in TRM may result 
in an increase in the number of Ca2+ channels, following which 
Ca2+ current may be elevated, and a long-lasting depolariza-
tion shift accompanied by repetitive firing may be induced, 
which may contribute to the enhanced neuronal excitability in 
epilepsy (41). Thus, the present study revealed that the upregu-
lated expression of CaV1.2 in the hippocampus of TRM may be 
involved in the generation of epileptiform activity and underlie, 
at least in part, the observed seizure phenotype in TRM.
The present data also demonstrated the upregulation of 
co-localization of CaM and CaV1.2 in the TRM hippocampus, 
and the combination of CaM and CaV1.2 may activate the 
Ca2+ channel and, ultimately, elevate the level of excitability 
in neurons. Notably, the distribution and expression of CaM 
and CaV1.2 in the cortex was opposite to that observed in the 
hippocampus in the TRM, indicating a possible compensa-
tory response aimed at counteracting hyperexcitability in the 
cortex of the TRM. Several previous studies have reported 
controversy in the change of CaMKII in different models of 
epilepsy. Selective suppression of CaMKII activity results in 
alterations in Ca2+ homeostasis and the development of SREDs 
in hippocampal neurons (46). Additionally, the expression of 
CaMKIIα is decreased in pentylenetetrazol-kindled rats (47). 
Another study demonstrated that the expression of p-CaMKII 
is upregulated in dendritic spines during epileptiform activity 
in vitro (48). This may be due to factors including different 
epilepsy models and brain regions. The present study demon-
strated that the expression of p-CaMKII in the hippocampus 
was downregulated. This may be due to Ca2+ being overloaded 
in epilepsy, which upregulated the expression of CaM, following 
which Ca2+/CaM-dependent enzymes were adjusted and the 
activity of CaMKII was restrained. However, the expression 
of p-CaMKII in the cortex was upregulated, which disagreed 
with the expression in the hippocampus and may be a compen-
satory response in the cortex. Notably, the expression levels 
of p-CaMKII were particularly low in the cerebellum. Thus, 
sustained Ca2+ overload may have caused a sharp increase in 
CaMKII auto-phosphorylation, which resulted in the reduction 
in CaMKII and p-CaMKII. In the in vitro model, the expres-
sion levels of p-CaMKII and CaV1.2 were downregulated, 
while that of CaM remained unchanged. Similar to previous 
studies, the reason for this may be that SREDs inhibited the 
activity of CaMKII and restrained its substrate (23,24).
The limitation of the present study lies in the in vivo and 
in vitro models, which may represent different types of 
models. To a certain extent, the hippocampal neuronal 
culture model can be considered an acute seizures model, 
and the neurons treated with Mg2+-free solution for 3 h may 
be not sufficient to fully undergo the molecular and cellular 
changes associated with the development of epileptogen-
esis. By contrast, TRM rats are genetic epileptic animals 
exhibiting spontaneous seizures, which can be considered 
a chronic model of epilepsy. Therefore, it is not surprising 
that the discrepancy was observed in the results of these 
two models. A noteworthy findings of the present study was 
that the CaV1.2-CaM and CaMKII-CaM complexes were 
widely co-localized in the TRM hippocampus, indicating 
that the association between these proteins may be involved 
in TRM seizures. The present study hypothesized that when 
[Ca2+] I increases in TRM, Ca2+ and CaM are combined 
to form the Ca2+/CaM complex, facilitating the affinity of 
CaM and CaV1.2. Additionally, CaMKII was activated by 
auto-phosphorylation when it combined with the Ca2+/CaM 
complex. Furthermore, increased CaM can be co-localized 
to the membrane with CaV1.2, leading to the upregula-
tion and increased activity of CaV1.2, which contribute to 
enhanced neuronal excitability and results in TRM seizures. 
Collectively, the present study demonstrated abnormal 
changes in the Ca2+/CaV1.2/CaM/CaMKII signaling pathway 
in TRMs and in the hippocampal neuronal culture model. 
Altering the expression of CaV1.2, CaMKII and CaM may 
lead these to become potential targets for therapy in epilepsy 
or seizures. TRMs and the hippocampal neuronal culture 
model can be screened for effective specific VDCC subtypes 
for the treatment of epilepsy or seizures.
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